Matthew Mingrone, MD
Otolaryngology/Facial Plastic Surgery · San Francisco, CANPI 1912029919
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (40.2%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Aerin Medical Inc. at 43.9% of the total. Reporting peaked in 2021 at $3,143 and has fallen 70.1% since, to $939 in 2025.
Across 118 payments — averaging $78.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$4K
- Medical Device Business Services, Inc.$2K
- Smith+Nephew$1K
- Optinose US, Inc.$617
- Regeneron Healthcare Solutions, Inc.$550
- Acclarent, Inc$245
- plus $1K from 12 others
What the payments were for
- Consulting fees$4505%
- Speaking & faculty fees$2,47527%
- Travel & lodging$2,49627%
- Food & beverage$3,74140%
- Education$1331%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 27 | $4,085 |
| Medical Device Business Services, Inc. | 8 | $1,542 |
| Smith+Nephew | 8 | $1,166 |
| Optinose US, Inc. | 18 | $617 |
| Regeneron Healthcare Solutions, Inc. | 22 | $550 |
| Acclarent, Inc | 3 | $245 |
| Sanofi | 3 | $174 |
| GSK | 6 | $147 |
| Stryker | 5 | $140 |
| Intersect ENT, Inc. | 5 | $130 |
| Regeneron | 1 | $107 |
| Sanofi-aventis U.S. LLC | 1 | $99 |
| Alk-abello, Inc | 1 | $96 |
| Amgen | 3 | $76 |
| Inspire Medical Systems, Inc. | 3 | $49 |
| Xoran Technologies LLC | 1 | $31 |
| Cook Medical LLC | 2 | $24 |
| Medacta USA, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$2,192
- RHINAER STYLUS$2,192
- PROCISE Tonsil$900
- Vivaer RF Stylus$713
- VivAer$450
- RhinAer$450
- Xhance$375
- DUPIXENT$367
- TruDi$140
How this compares
$9,295 in reported general payments places this provider in the 85th percentile of 102 otolaryngology/facial plastic surgery providers in California.
See all otolaryngology/facial plastic surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 17 | $2,054 |
| Azelastine Hcl | 34 | $1,032 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $210 |
| Ipratropium Bromide | 12 | $116 |
| Azithromycin | 16 | $42 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology/facial plastic surgery in San Francisco
- Raj DedhiaSan Francisco$5K
- Grace WuSan Francisco$1K
- Sarmela SunderLancaster$85K
- Vasu DiviStanford$51K
- Jen ChowArcadia$26K
- Ryan CasserlyMonterey$23K
- Ritvik MehtaCarlsbad$13K
- Alexis FurzeNewport Beach$12K
- Jahangir SharifiLos Angeles$12K
- Henry NguyenRancho Cucamonga$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.